ClinicalTrials.gg
Not yet recruitingNCT07592624MediTUpdated Sep 16, 2026

Evaluation of an Instructional Video About Medication Management During Admission and Medication Adherence for Kidney Transplantation and in the Outpatient Clinic in a Dutch University Hospital.

An interventional study of Instructional video about medication administration in Kidney Transplant, Adult and Medication Adherence, sponsored by Erasmus Medical Center. Not yet recruiting at 1 site in Netherlands. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-16.

Sponsored by Erasmus Medical Center · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
308
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this RCT is to evaluate the effect of the instructional video on improving patient compliance and reducing medication errors. The study will include adult kidney transplant recipients (18 years or older) at Erasmus MC who have undergone a kidney transplantation starting January 2026.

The main questions it aims to answer:

The primary aim of this study is to assess whether our developed video instruction, compared with the traditional verbal instruction, both of which are given shortly before training during admission, reduces the number of medication errors in kidney transplant patients.

The study will also examine the correlation between patient characteristics (such as age, comorbidities, and language proficiency) and medication errors. Additionally, patient-reported medication errors will be measured through a questionnaire completed during follow-up visits at the outpatient clinic, which is part of standard care.

The instructional video will be evaluated by a short questionnaire.

02

Conditions studied

  • Kidney Transplant
  • Adult
  • Medication Adherence
  • Instruction Videos

Browse trials for

03

In context

Medication Adherence

937 studies on the registry are indexed under Medication Adherence; 159 are open to participants now.

This study's planned enrollment of 308 is above the median of 120 across 768 interventional studies indexed under Medication Adherence.

Browse Medication Adherence studies →

Lead sponsor

Erasmus Medical Center is the lead sponsor of 478 studies on the registry; 183 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • The patient is able to take the medication independently or with the help of someone else (professionals not included).
  • After admission, the patient is discharged to their own home or home of friend/relative.
  • The patient had a follow up at the outpatient clinic in the Erasmus Medical Center for at least one year after transplantation.
  • The patient is able to read the medication list or an illiteracy-friendly medication list.

Exclusion criteria

Exclusion Criteria:

  • Patients under 18 years of age
  • Patients who got discharged with a medication dispenser
  • Refusal to participate in the study.
  • Cognitive impairments that hinder participation.
  • Patients and/or family who can not understand (language barrier) the instructional video.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
308 participants (estimated)

Study arms

  • No intervention
    Verbal instruction

    Patients receive the verbal instruction about medication training from the nurses.

  • Experimental
    Video instruction

    Patients receive the instruction video about medication training from the nurses.

    Other: Instructional video about medication administration

Interventions

  • OtherInstructional video about medication administration

    Self developed instructional video for a Dutch university hospital, for Dutch kidney transplant patients. Instructional video is about medication administration during admission.

06

What researchers measure

Primary outcomes

  1. Incidence and type of medication errors during admission

    The primary outcome of this study will be the incidence (number of medication errors) and type of medication errors ( 1)Medication preparation omitted, 2) Incorrect dosage, 3) Incorrect administration at the scheduled time, 4), Medication discontinued inappropriately, 5)Error not documented by the nurse) during admission, evaluated through direct observation by healthcare providers. These errors will be documented and reported via patient portals by nurses.

    Time frame: During admission

Secondary outcomes

  1. Patient characteristics

    Age (in years), gender (male/female/nonbinair), country of origin, language proficiency, number of previous organ transplantations, donor type of the kidney transplant (DCD, DBD, Living), and renal replacement therapy (HD/PD/Pre-emptive).

    Time frame: During admission

  2. Evaluation of the instructional video

    Structured questionnaire with the following questions: * Was the instructional video clear and easy to understand? (open answer) * Did you find the instructional video easy to follow? (open answer) * Do you have any suggestions for improvements? (open answer)

    Time frame: At the end of admission

  3. BAASIS

    Participants will complete a patient-reported questionnaire (BAASIS) every three months during the first year after transplantation. The questionnaire consists of five yes/no questions related to medication errors occurring in the home setting. The questions will ask whether the participant has: 1. Forgotten to take their medication, (yes/no) 2. Taken the wrong dose of medication, (yes/no) 3. Taken medication at the wrong time, (yes/no) 4. Mixed up medications, (yes/no) 5. Not taken their medication due to confusion or difficulty. (yes/no) The goal is to evaluate whether there is a reduction in home-reported medication errors for those who receive a different medication management training method in the hospital.

    Time frame: During the first year follow up at the out patient clinic after kidney transplantation in the Erasmus MC

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 16, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07592624
Responsible party
Jacqueline van de Wetering (Principal Investigator, Erasmus Medical Center) — Principal investigator
First posted
May 18, 2026
Start date
Jan 1, 2027 (estimated)
Primary completion
Jan 1, 2029 (estimated)
Completion
Dec 31, 2029 (estimated)
Last update
Sep 16, 2026

Study contacts

Myrthe van der Zanden, MSc, Drs
Contact
m.vanderzanden@erasmusmc.nl
+31650094899
Jacqueline van de Wetering, MD, Dr.
study chair · Erasmus Medical Center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in May 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion